Back to top

Leap Therapeutics to cut workforce by 75%, explore strategic alternatives

Leap is taking additional steps to reduce spending and preserve capital. Over the next two months as the DeFianCe study completes, the Company will...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Leap Therapeutics, Inc. (LPTX)